DE602006015235D1 - Polymere zusammensetzungen auf 4-azacaprolactonbasis, die sich für die herstellung von biologisch abbaubaren medizinischen geräten und als beschichtungen für medizinische geräte eignen - Google Patents
Polymere zusammensetzungen auf 4-azacaprolactonbasis, die sich für die herstellung von biologisch abbaubaren medizinischen geräten und als beschichtungen für medizinische geräte eignenInfo
- Publication number
- DE602006015235D1 DE602006015235D1 DE602006015235T DE602006015235T DE602006015235D1 DE 602006015235 D1 DE602006015235 D1 DE 602006015235D1 DE 602006015235 T DE602006015235 T DE 602006015235T DE 602006015235 T DE602006015235 T DE 602006015235T DE 602006015235 D1 DE602006015235 D1 DE 602006015235D1
- Authority
- DE
- Germany
- Prior art keywords
- medical devices
- coatings
- azacaprolactone
- manufacture
- compositions suitable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71189505P | 2005-08-25 | 2005-08-25 | |
PCT/US2006/030952 WO2007024481A2 (en) | 2005-08-25 | 2006-08-09 | 4-aza-caprolactone-based polymeric compositions useful for the manufacture of biodegradable medical devices and as medical device coatings |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006015235D1 true DE602006015235D1 (de) | 2010-08-12 |
Family
ID=37772129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006015235T Active DE602006015235D1 (de) | 2005-08-25 | 2006-08-09 | Polymere zusammensetzungen auf 4-azacaprolactonbasis, die sich für die herstellung von biologisch abbaubaren medizinischen geräten und als beschichtungen für medizinische geräte eignen |
Country Status (6)
Country | Link |
---|---|
US (1) | US8137687B2 (de) |
EP (1) | EP1984036B1 (de) |
JP (1) | JP5188971B2 (de) |
AT (1) | ATE472340T1 (de) |
DE (1) | DE602006015235D1 (de) |
WO (1) | WO2007024481A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070264307A1 (en) * | 2006-05-15 | 2007-11-15 | Medtronic Vascular, Inc. | Biodegradable Modified Caprolactone Polymers for Fabricating and Coating Medical Devices |
US10155881B2 (en) | 2007-05-30 | 2018-12-18 | Abbott Cardiovascular Systems Inc. | Substituted polycaprolactone for coating |
JP2012504031A (ja) | 2008-09-29 | 2012-02-16 | カルディアック バルブ テクノロジーズ,インコーポレーテッド | 心臓弁 |
CA2739275C (en) | 2008-10-01 | 2017-01-17 | Impala, Inc. | Delivery system for vascular implant |
AU2010236288A1 (en) | 2009-04-15 | 2011-10-20 | Cardiaq Valve Technologies, Inc. | Vascular implant and delivery system |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
CN102659710B (zh) * | 2011-12-31 | 2015-05-06 | 浙江大学 | 4-(2-甲基丙烯酰基)-7-氧代-1,4-氧氮高氢杂*及其制备方法和应用 |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US10293044B2 (en) | 2014-04-18 | 2019-05-21 | Auburn University | Particulate formulations for improving feed conversion rate in a subject |
CN106232106B (zh) | 2014-04-18 | 2020-08-11 | 奥本大学 | 用于诱导先天性和适应性免疫力的颗粒状疫苗制剂 |
US10583199B2 (en) | 2016-04-26 | 2020-03-10 | Northwestern University | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs |
AU2017371223B2 (en) | 2016-12-09 | 2023-04-27 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
CN114786629A (zh) | 2019-11-19 | 2022-07-22 | 真复灵公司 | 用于植入物在前列腺尿道中的准确展开和成像的系统、装置和方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670161A (en) * | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
IN2014DN10834A (de) * | 2001-09-17 | 2015-09-04 | Psivida Inc | |
DK1764118T3 (da) | 2002-02-15 | 2010-11-08 | Gilead Palo Alto Inc | Polymer-coating til medicinske anordninger |
SE0202619D0 (sv) * | 2002-09-05 | 2002-09-05 | Fredrik Nederberg | New Polymers and Applications |
US20040180131A1 (en) * | 2003-03-14 | 2004-09-16 | Medtronic Ave. | Stent coating method |
EP1933845A2 (de) * | 2005-08-25 | 2008-06-25 | Medtronic Vascular, Inc. | Stickoxid freisetzende biologisch abbaubare polymere als medizinprodukte und beschichtungen dafür |
US20070237803A1 (en) * | 2006-04-11 | 2007-10-11 | Medtronic Vascular, Inc. | Biodegradable Biocompatible Amphiphilic Copolymers for Coating and Manufacturing Medical Devices |
-
2006
- 2006-08-09 AT AT06801001T patent/ATE472340T1/de not_active IP Right Cessation
- 2006-08-09 US US12/064,108 patent/US8137687B2/en not_active Expired - Fee Related
- 2006-08-09 DE DE602006015235T patent/DE602006015235D1/de active Active
- 2006-08-09 EP EP06801001A patent/EP1984036B1/de active Active
- 2006-08-09 WO PCT/US2006/030952 patent/WO2007024481A2/en active Application Filing
- 2006-08-09 JP JP2008527957A patent/JP5188971B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007024481A2 (en) | 2007-03-01 |
US20080233169A1 (en) | 2008-09-25 |
EP1984036A2 (de) | 2008-10-29 |
ATE472340T1 (de) | 2010-07-15 |
WO2007024481A3 (en) | 2008-09-12 |
JP2009505725A (ja) | 2009-02-12 |
EP1984036B1 (de) | 2010-06-30 |
JP5188971B2 (ja) | 2013-04-24 |
US8137687B2 (en) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006015235D1 (de) | Polymere zusammensetzungen auf 4-azacaprolactonbasis, die sich für die herstellung von biologisch abbaubaren medizinischen geräten und als beschichtungen für medizinische geräte eignen | |
WO2007030266A3 (en) | Nitric oxide-releasing polymers derived from modified polyimines | |
WO2009005909A3 (en) | Biodegradable triblock copolymers for implantable devices | |
CY1115891T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση των διαταραχων του εσω ωτος | |
CY1118655T1 (el) | Χρηση 2,4-πυριμιδινοδιαμινων για τη θεραπεια της αθηροσκληρωσης | |
EP2309990A4 (de) | Mit wirkstoff beladene polymernanopartikel sowie verfahren zu ihrer herstellung und verwendung | |
ATE523487T1 (de) | 2-methylen-1-alpha-dihydroxy-19,21-dinor-vitami - d3-analoga und ihre anwendung | |
WO2007024501A3 (en) | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore | |
MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
ATE437663T1 (de) | Legierungszusammensetzungen und diese enthaltende vorrichtungen | |
MX2009003821A (es) | Compuestos de n-aril pirazol para usarse contra la diabetes. | |
EA201000946A1 (ru) | Бициклические производные для применения при лечении состояний, связанных с андрогенным рецептором | |
EA201170040A1 (ru) | Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и способы их получения и применения | |
EP2993165A3 (de) | Verbindungen mit (substituiertem phenyl-)propenalbestandteil, derivate, biologische aktivität und verwendung davon | |
DE602004024898D1 (de) | System und set zum einbringen eines restorativen materials | |
MX2009006627A (es) | Quinazolinas para la inhibicion de pdk1. | |
ATE480543T1 (de) | Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase | |
ATE449604T1 (de) | Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren | |
MX366832B (es) | Composiciones de farmaco de liberacion sostenida convenientemente implantables. | |
ATE451130T1 (de) | Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen | |
WO2009141823A3 (en) | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases | |
ATE496081T1 (de) | Beschichtungen für implantierbare vorrichtungen mit poly(hydroxy-alkanoaten) und disäure- bindungen | |
DE602006009834D1 (de) | Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung |